Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics.

Marco ChiappettaDiomira TabaccoAmedeo Giuseppe IaffaldanoJessica EvangelistaMaria Teresa CongedoCarolina SassorossiElisa MeacciEttore D'ArgentoEmilio BriaEmanuele VitaGiampaolo TortoraLuca BoldriniDiepriye Charles-DaviesMariangela MassaccesiAntonella MartinoCiro MazzarellaVincenzo ValentiniStefano MargaritoraFilippo Lococo

Published in: Life (Basel, Switzerland) (2022)

Clinical response aided the stratification of prognosis in patients that underwent multimodal treatment for stage III NSCLC. Adjuvant therapy seemed to be an important option in these patients, while node ratio was a strong prognosticator in patients with persistent nodal involvement.

Keyphrases

end stage renal disease
lymph node
small cell lung cancer
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
minimally invasive
squamous cell carcinoma
neoadjuvant chemotherapy
acute coronary syndrome
pain management
cell therapy
brain metastases